PND6 CLINICALLY RELEVANT REDUCTION OF MIGRAINE SYMPTOMS BY FREMANEZUMAB IN PATIENTS WITH UP TO ONE PREVENTIVE MIGRAINE PROPHYLAXIS TREATMENT IN THE PAST

Authors
Category Primary study
JournalValue in Health
Year 2019
This article has no abstract
Epistemonikos ID: 09ff13b808e1c6e5b4b34ee911fc1ba1d0863338
First added on: Feb 11, 2025